For as an adjunct to coumarin anticoagulants in the prevention of postoperative thromboembolic complications of cardiac valve replacement and also used in prevention of angina.
Dipyridamole
Description | |
---|---|
2,2',2'',2'''-(4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl)tetraethanol | |
58-32-2 | |
C24H40N8O4 | |
2,2,2,2-(4,8-dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilotetraethanol;Dipyridamole (FDA);1,1',1'',1'''-{[4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl]dinitrilo}tetraethanol;Dypyridamole; | |
A phosphodiester, cGMP, and non-specific nucleoside transport inhibitor |